14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $5.34 $19.02 Tuesday, 7th May 2024 CNTA stock ended at $9.67. This is 4.54% more than the trading day before Monday, 6th May 2024. During the day the stock fluctuated 8.73% from a day low at $8.93 to a day high of $9.71.
90 days $17.30 $19.02
52 weeks $16.32 $20.85

Historical Centessa Pharmaceuticals Limited prices

Date Open High Low Close Volume
Jul 21, 2023 $7.49 $7.63 $6.77 $7.30 128 168
Jul 20, 2023 $7.51 $7.84 $7.25 $7.29 78 107
Jul 19, 2023 $7.72 $7.93 $7.33 $7.49 102 684
Jul 18, 2023 $8.00 $8.19 $7.30 $7.69 119 561
Jul 17, 2023 $7.63 $7.98 $7.42 $7.93 85 000
Jul 14, 2023 $8.06 $8.06 $7.34 $7.57 89 210
Jul 13, 2023 $8.50 $8.50 $7.36 $7.48 505 191
Jul 12, 2023 $7.80 $8.64 $7.74 $8.24 471 870
Jul 11, 2023 $6.50 $7.35 $6.54 $7.30 299 488
Jul 10, 2023 $6.04 $6.47 $5.94 $6.46 46 385
Jul 07, 2023 $6.10 $6.32 $5.80 $6.15 8 194
Jul 06, 2023 $6.00 $6.17 $5.90 $6.01 20 433
Jul 05, 2023 $6.00 $6.28 $5.81 $6.04 46 821
Jul 03, 2023 $6.28 $6.33 $5.77 $6.05 25 748
Jun 30, 2023 $5.99 $6.27 $5.85 $6.19 132 655
Jun 29, 2023 $6.07 $6.25 $5.24 $5.90 118 744
Jun 28, 2023 $5.98 $6.14 $5.71 $6.14 80 082
Jun 27, 2023 $6.99 $6.99 $5.85 $5.98 437 446
Jun 26, 2023 $6.59 $7.01 $6.27 $6.90 237 208
Jun 23, 2023 $6.22 $7.19 $5.95 $6.60 428 579
Jun 22, 2023 $5.60 $6.55 $5.20 $6.35 490 256
Jun 21, 2023 $5.70 $5.70 $5.47 $5.69 209 141
Jun 20, 2023 $5.70 $5.70 $4.91 $5.50 183 290
Jun 16, 2023 $5.51 $5.70 $5.45 $5.68 116 557
Jun 15, 2023 $4.95 $5.48 $4.75 $5.44 48 550
Click to get the best stock tips daily for free!

About Centessa Pharmaceuticals Limited

Centessa Pharmaceuticals Limited Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; and SerpinPC, an activated protein C inhibitor, which is in Phase IIa clinical development for the treatm... CNTA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT